Phenazone Metabolism in Patients with Liver Disease
- 1 February 1976
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 6 (1) , 21-26
- https://doi.org/10.1111/j.1365-2362.1976.tb00489.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Assessment of Aminopyrine Metabolism in Man by Breath Analysis after Oral Administration of14C-AminopyrineNew England Journal of Medicine, 1974
- Clearance of Antipyrine‐Dependence of Quantitative Liver FunctionEuropean Journal of Clinical Investigation, 1974
- Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of manBiochemical Pharmacology, 1974
- Abstracts of Papers Submitted to the American Association for the Study of Liver DiseasesGastroenterology, 1973
- Determinants of serum antipyrine half-lives in patients with liver diseaseGut, 1973
- Rapid gas-liquid chromatographic estimation of antipyrine in plasmaJournal of Pharmacy and Pharmacology, 1973
- Metabolism of amylobarbitone in patients with chronic liver diseaseBritish Journal of Pharmacology, 1972
- The role of the liver in drug metabolismThe American Journal of Medicine, 1970
- PHENYLBUTAZONE AND ISONIAZID METABOLISM IN PATIENTS WITH LIVER DISEASE IN RELATION TO PREVIOUS DRUG THERAPYThe Lancet, 1968
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951